自我评估抑郁症严重程度,以指导在维护ECT期间的复发潜在分层.
Liselotte Gezels1, Linda Van Diermen2, Violette Coppens1
1Scientific Initiative for Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Journal of affective disorders
|July 22, 2025
概括
自我报告的抑郁症尺度,如IDS-SR,可靠地帮助决定大抑郁症 (MDD) 患者的维护电治疗 (M-ECT) 频率. 这可以个性化治疗,减少复发率.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 重度抑郁症 (MDD) 治疗决策,特别是电疗法 (ECT),由于复发率高,至关重要.
- 维持性电治疗 (M-ECT) 对于预防复发至关重要,症状驱动的方法越来越受欢迎.
- 自我报告尺度与临床医生评估在M-ECT决策中的实用性需要进一步研究.
研究的目的:
- 在指导M-ECT决策时,与临床医生评分版本 (IDS-C) 相比,评估抑郁症症状清单 (IDS-SR) 的自我报告版本的可靠性.
- 评估IDS-SR和IDS-C之间的一致性,以确定M-ECT频率的MDD患者.
- 探索自我报告措施的潜力,以优化个性化的M-ECT和减少资源负担.
主要方法:
- 从PRASED研究中分析了96名MDD患者的缓解后急性ECT子样本.
- 根据复发潜力对患者进行分类,使用每周的IDS-C得分来指导M-ECT频率 (0,1或2次).
- 在M-ECT期间,在五个月的评估中,使用类内相关系数 (ICC) 评估了IDS-C和IDS-SR之间的协议.
主要成果:
- IDS-SR与IDS-C达成良好至优异的协议,ICC在0.73到0.85.5之间.
- 基于两种尺度的决策结果在81%的案例中是一致的.
- 与IDS-C相比,IDS-SR在16%的病例中表明需要更多的M-ECT会话,这表明一些自我报告高估.
结论:
- IDS-SR是一种可靠的自我评估工具,用于在M-ECT期间监测抑郁症严重程度,与临床医生评级相似.
- 使用像IDS-SR这样的自我报告量表可以减少临床医生的资源负担,从而有可能实现更广泛的个性化M-ECT.
- 以可靠的自我报告措施为指导的个性化M-ECT可以通过有效降低MDD复发率来改善患者的结果.
相关概念视频
Electroconvulsive Therapy
198
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
198
Depression: Overview
346
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
346
Depressive Disorders: Etiology
172
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
172
Depressive Disorders: MDD and Dysthymia
219
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
219
Psychosis: Goals of Pharmacotherapy
210
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
210
Long-term Depression
31.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.5K


